HLA class II frequencies of patients with hepatitis C virus (HCV) induced end stage liver disease (n=39) versus blood donors (n=170, control group 2) who were typed by apolymerase chain reaction-sequence specific oligonucleotide procedure
| Blood donors | HCV induced end stage liver cirrhosis | p Value | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | ||||||
| DRB1*1 | 31 | 17.6 | 5 | 12.8 | NS | ||||
| DRB1*2 | 68 | 40.0 | 12 | 30.8 | NS | ||||
| DRB1*3 | 41 | 24.1 | 12 | 30.8 | NS | ||||
| DRB1*4 | 42 | 24.7 | 5 | 12.8 | NS | ||||
| DRB1*7 | 41 | 24.1 | 13 | 33.3 | NS | ||||
| DRB1*8 | 11 | 6.5 | 1 | 2.6 | NS | ||||
| DRB1*9 | 4 | 2.4 | 2 | 5.1 | NS | ||||
| DRB1*10 | 0.0 | 1 | 2.6 | NS | |||||
| DRB1*11 | 38 | 22.4 | 3 | 7.7 | 0.04 | ||||
| DRB1*12 | 9 | 5.3 | 2 | 5.1 | NS | ||||
| DRB1*13 | 21 | 12.4 | 10 | 25.6 | NS | ||||
| DRB1*14 | 11 | 6.5 | 4 | 10.3 | NS | ||||
| 170 | 39 | ||||||||
| DQB1*02 | 64 | 37.6 | 21 | 53.8 | NS. | ||||
| DQB1*03 | 100 | 58.8 | 15 | 38.5 | 0.033 | ||||
| DQB1*04 | 11 | 6.5 | 3 | 7.7 | NS | ||||
| DQB1*05 | 49 | 28.8 | 9 | 23.1 | NS | ||||
| DQB1*06 | 79 | 46.5 | 19 | 48.7 | NS | ||||
| 170 | 39 | ||||||||